Numerous investigations have been conducted on substances which act antago nistically against the various vitamins . In the case of pantothenic acid (PaA) , numerous derivatives and analogs have been synthesized and their PaA activity or antagonistic action against PaA has been investigated (1) (2) (3) (4) . The antagonistic action of w-methylpantothenic acid (5 , 6) and pantoyltaurine (7, 3) , in particular , against PaA in microorganisms and production of PaA deficiency i n animals are well known.
In the Pediatrics Department of the Osaka University , various derivatives of ry-aminobutyric acid (GABA) have been synthesized f or the purpose of facilitating the transfer of GABA to the brain . The effect of these compounds on excitability of the brain was examined and it was found that homopantothenic acid (HOPA) , Six grams of metallic sodium were dissolved in 150ml of methanol, 26g of GAGA was added and the whole was allowed to react for about 4 hours to give 
Bacterial Inoculant
The preliminary medium described in Table  3 
Culture Medium
The medium for quantitative determination and the restricted medi um shown i n Table 4 were prepared according to USP (12) . To 2ml of the medium was added the sterile aqueous solution of the test substance , the total volume made up to 4ml and used for cultivation . Table  6 . newly hatched chicks were given daily. From the day of start of HOPA admin istration, 15-20g of the synthetic feed indicated in Table 9 were given each day.
Administration of HOPA and PaA
To ascertain the toxicity of HOPA, mice were injected intraperitoneally with 3g/kg, about half an amount of LD50 (5.72g/kg) of the compound (9) , and used only after no ill effect was observed.
A dose corresponding to 100g of the body weight was dissolved in water to make a total volume of 1.0ml and administered orally once daily on a fasting stomach. PaA was administered by dissolving 1.1mg/kg/day of the calcium salt (equivalent to 1.0mg of PaA) and giving it directly by mouth. The interval be tween the two was at least one hour. 4 Fig. 6 compares the findings in the PaA deficient group and the 1 mg/kg/day PaA group and it may be seen that in the PaA deficient group, the body weight showed no increase from the 5th day, the feathers became markedly rough from the 8th day and loss of feathers became apparent.
Preliminary Experiment
In the PaA group , on the other hand, the body weight gain was normal and no abnormalities in the feathers were seen. At 10 and 14days, the difference in average weight was 14 .4 and 42.0g respectively. In the deficient group, there was a pronounced decrease in the liver CoA level on the 10th day, whereas it was normal in the PaA group. From the 14th day, PaA was supplemented in a dose of 5mg/kg/day, whereupon body weight began to increase from the 4th day and the feathers gradually became normal. normal values. It was revealed in this experiment that PaA deficiency was in duced by the PaA deficient diet used and the deficiency was overcome by the administration of PaA. Regular growth of the chick was maintained by 1mg/kg/ day of PaA. PaA was therefore given in a dose of 1mg/kg/day in the experi ments which followed.
Administration of 1g/kg of HOPA
Comparison of the weight gain curve between the HQPA group and the con trol shows that at 14days, there was little difference; the average daily weight gain was 3.3g in the HQPA group and 3.7g in the control (Fig. 7) . No signs of PaA deficiency were apparent. The liver CoA level on the 7th day was almost the same in the HQPA group and the control but a slight decrease was noted in the HQPA group on the 13th day. 3. Administration of 2g/kg of HOPA As may be seen in Fig. 8 , the body weight continued to increase in the HOPA group after 2 weeks but from the third day, the rate of increase was smaller 4 Administration of 2.5g/kg of HOPA From the 4th day, a difference in the rate of body weight gain became ap parent between the HOPA group and the control and on the 5th day, loss of feathers increased, activity disappeared and from the 7th day , weight gain stopped. The average daily weight gain was 2.3g in the HOPA group and 3 .3g in the control. The liver CoA was markedly decreased on the 10th day (Fig . 9) 5. Administration of 3g/kg of HOPA As indicated in Fig. 10 , the feathers started to become rough , gradually fall out, and activity was lost but weight gain continued up to the 9th day . The average daily weight gain in this period was 2.6g in the HOPA group and 5 .5g in the control. On the 9th day, body weight began to decrease together with loss of appetite and chicks began to die from the 11th day. With decrease in body weight, the wings became dry and drooping movement became slow and a trend to fall backwards became apparent.
Inflammation of the eyelids also occurred and was so severe that the eyes could not be opened because of the discharge in some cases. When the amount of PaA was increased to 3mg/kg/day on the 12th day, so that the ratio to HOPA was 1:1,000, the body weight began to increase from the next day.
The liver CoA level was markedly decreased on the 8th day but 5days after PaA had been increased, it returned to normal. from the 3rd day, the feathers started to become rough and a trend for diarrhea was noted. From the 8th day, body weight began to decrease and some of the chicks died. On the 9th day, almost no feed was taken and on the 10th day, there was a pronounced decrease in weight and the number of deaths increased. The amount of PaA was then increased to 5mg/kg/day from the 10th day; whereupon feed was again taken and weight began to increase. From the 15th day, PaA was increased to 10mg/kg/day and on the 22nd day, there was con siderable improvement in the deficiency symptoms despite the continued adminis tration of HOPA (Fig. 11) . The liver CoA level was already markedly decreased on the 6th day, but a restoration to normal was found 12days after PaA had been increased.
The liver in cases where the CoA level was decreased following administration of more than 2g/kg/day of HOPA, was grayish in color and the gall bladder was extremely swollen. When the CoA had been restored to a normal level by in creasing PaA, the color of the liver and the size of the gall bladder returned to normal again.
SUMMARY

Administration
of HOPA in a dose of more than 2g/kg/day in the chick resulted in suppression of weight gain, decrease of liver CoA, alteration in the color of the liver and swelling of the gall bladder and signs similar to PaA de fi ciency also became apparent.
Decrease in body weight occurred with a ratio (PaA/HOPA) of 1:2,500-3,000 and decline in liver CoA occurred with a ratio (PaA/HOPA) of 1:2,000-2,500. The changes were reversible by increasing the ratio (PaA/HOPA) to 1:1,000. As this strong antagonistic action against PaA was observed in Lactobacillus , th e antagonistic effect of HOPA showing the strongest action was examined in the chick. It was found that of the symptoms characteristic to PaA deficiency (19) , only decline of body weight, loss of appetite and changes in the skin occurred , whereas other manifestations did not become apparent . Despite the finding that the relative antagonistic action of HOPA was 150 in L . arabinosus, signs of PaA deficiency were induced in the chick only by doses more than 2g/kg/day .
Compared to the fact that PaA deficiency occurs in the mouse when w -CHs-PaA is administered in a ratio of PaA/w-CH3PaA 1:100 (5) , it can be said that the antagonistic action of HOPA against PaA is quite weak . In general, it is consi dered that the compounds antagonistic to PaA in bacteria will induce PaA defi ciency symptoms in animals with difficulty (18) . Snell et al. (8) report that PaA deficiency signs are induced with oral administration of 0 .2g/kg of pantoyltaurine, whereas Woolley (20) and Unna (21) report that deficiency manifestations rarely occur with this dosage.
That the symptoms occurring with administration of a large dose of HOPA are not toxic signs can be well accepted from the findings that the LD ,0 of HOPA i s 5.72g/kg and more than 2 times the value of PaA , 2.49g/kg, and the deficiency signs occuring with doses of 3g/kg/day or higher are eliminated by increasing the amount of PaA. Olson (22) reported that the liver CoA in the duckling on the fi fth day of PaA deficiency was markedly decreased but there are no reports on the changes in the liver CoA following administration of PaA antagonists . In the present study, it was found that when 2.5g/kg/day of HOPA is given for 9days, followed by 4g/kg/day for 5days, the liver CoA was markedly reduced . This reduction is readily restored by increasing the ratio of PaA/HOPA to 1:1 ,000, suggesting a competitive antagonism taking place in the organism .
It is believed from the decrease in liver CoA with oral administration of HOPA and restoration of the pathological symptoms and reduced liver CoA by increasing the amount of PaA that the symptoms in the chick are manifestations resulting from PaA deficiency.
The following assumption may be made regarding the mechanism of inhibition of PaA by PaA antagonists.
Shils (23) has proposed that the PaA antagonistic action of w-CH3-PaA is an obstruction of the biosynthesis from PaA to CoA and Ariyama (6) states that the inhibitory effect will not appear unless there is a con version of w-CH3-PaA to w-methyl-pantotheine.
The results of the present study suggest that the PaA antagonistic action of HOPA derivatives lies in an obstruc tion of the pathway of biosynthesis of CoA from PaA. Designation of the exact step in the biosynthesis at which the obstruction takes place , however, must await further investigation.
